Table 2.

Clinical characteristics of LTG-induced cADRs group and LTG-tolerant group

	LTG-induced cADRs group (n = 16)	LTG-tolerant group (n = 50)	p value
Gender (male: female)	6:10	12:38	0.340
	1:2 (SJS/TEN)		1.000
	5:8 (MPE)		0.353
Mean age (years)	35.5 ± 21.7	38.2 ± 19.0	0.646
	52.3 ± 24.0 (SJS/TEN)		0.415
	32.0 ± 20.9 (MPE)		0.353
Starting dosage of LTG (mg/day)	51.6 ± 26.6	77.6 ± 62.0	0.109
	41.7 ± 14.4 (SJS/TEN)		0.325
	53.8 ± 28.6 (MPE)		0.186

No significant differences were observed in gender, mean age, and mean starting dosage of LTG between cases and LTG-tolerant controls